RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Visiomed Group Equity 2024

Visiomed Group Equity

24.27 M EUR

Visiomed Group Dividend yield

Ticker

ALVMG.PA

ISIN

FR0013481835

WKN

A2PZ7S

In 2024, Visiomed Group's equity was 24.27 M EUR, a 72.45% increase from the 14.07 M EUR equity in the previous year.

Visiomed Group Aktienanalyse

What does Visiomed Group do?

The Visiomed Group SA, based in France and founded in 2007, is a globally operating company specializing in the development and distribution of medical devices and healthcare products. With a wide range of innovative medical devices and technologies, Visiomed has become a leading provider in this field. The business model of Visiomed is based on developing innovative technologies in the healthcare sector and bringing them to the global market. The company specifically invests in research and development as well as building strategic partnerships and distribution networks. Visiomed has divided itself into different sectors to offer its customers a broad range of healthcare products. The core areas of the company are Connected Health, Medical Care, and Oral Care. The Connected Health sector combines activities in the digital healthcare services and offers innovative solutions for monitoring and improving health. These include products such as ThermoFlash, the contactless infrared thermometer for measuring body temperature, or Bewell Connect, the system for monitoring blood pressure, pulse, and weight. In the Medical Care sector, Visiomed offers devices for medical diagnostics, therapy, and care. These include products such as the electronic stethoscope Stet-o-mate, the X'traseal wound care system, and the cable ECG Easy ECG. The Oral Care sector includes products for oral and dental care. These include the ZenCare electric ultrasonic toothbrush head, the OralJet tongue cleaner, and the Teeth Whitener teeth whitening set. Visiomed is proud to offer a variety of healthcare products tailored to the needs of consumers and professionals alike. The company is dedicated to providing its customers with innovative and effective solutions to improve healthcare worldwide. Visiomed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Visiomed Group's Equity

Visiomed Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Visiomed Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Visiomed Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Visiomed Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Visiomed Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Visiomed Group Stock

What is the equity of Visiomed Group this year?

Visiomed Group has equity of 24.27 M EUR this year.

What was the equity of Visiomed Group compared to the previous year?

The equity of Visiomed Group has increased/decreased by 72.45% increased compared to the previous year.

What impact does a high equity have on investors of Visiomed Group?

A high equity is advantageous for investors of Visiomed Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Visiomed Group?

A low equity can be a risk for investors of Visiomed Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Visiomed Group affect the company?

An increase in equity of Visiomed Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Visiomed Group affect the company?

A reduction in equity of Visiomed Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Visiomed Group?

Some factors that can affect the equity of Visiomed Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Visiomed Group so important for investors?

The equity of Visiomed Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Visiomed Group take to change the equity?

To change equity, Visiomed Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Visiomed Group pay?

Over the past 12 months, Visiomed Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Visiomed Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Visiomed Group?

The current dividend yield of Visiomed Group is .

When does Visiomed Group pay dividends?

Visiomed Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Visiomed Group?

Visiomed Group paid dividends every year for the past 0 years.

What is the dividend of Visiomed Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Visiomed Group located?

Visiomed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Visiomed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Visiomed Group from 4/20/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/20/2024.

When did Visiomed Group pay the last dividend?

The last dividend was paid out on 4/20/2024.

What was the dividend of Visiomed Group in the year 2023?

In the year 2023, Visiomed Group distributed 0 EUR as dividends.

In which currency does Visiomed Group pay out the dividend?

The dividends of Visiomed Group are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Visiomed Group

Our stock analysis for Visiomed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Visiomed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.